For the best viewing experience of this website, please enable javascript in your browser. Thank you.

Welcome to the registration page for 11th Annual Symposium Otolaryngology Update in NYC

Presented by Weill Cornell Medicine’s
Department of Otolaryngology - Head and Neck Surgery


Thursday, October 25 – Friday, October 26, 2017
2-day Comprehensive Course

New York Marriott Marquis
1535 Broadway
(between 45th & 46th Street)
New York, NY 10036

7:30 - 8:00 am CME Registration and Continental Breakfast
Physicians: Regular Rate: $800 Early Bird Rate: $700.00 (Must register by 8/1/2017 – 9/1/2017)
Residents/Fellows/PAs/NPs: Regular Rate: $400 Early Bird Rate: $350.00 (Must register by 8/1/2017 – 9/1/2017)

Cancellation/Refund Policy
An administrative fee of $50 will be retained on all cancellations.
All requests for refunds must be in writing and received by 10/15/17.
After this date, no refunds are possible.

For More Information Contact:
Marie M. Toussaint, MPA
Credentialing Coordinator
Phone: 212-746-2226

Accreditation and Credit Designation Statements
Weill Cornell Medical College designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

It is the policy of Weill Cornell Medical College to adhere to ACCME Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored activities. All speakers, Course Directors, Co-Course Directors, planners, reviewers, and staff members participating in sponsored activities are expected to disclose relevant financial relationships pertaining to their contribution to the activity. Relationship information is analyzed to determine whether conflicts of interest exist. All conflicts of interest are resolved prior to participation in the planning or implementation of this activity. Presenters and authors are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.